ACAAI 2015 Annual Scientific Meeting

November 5, 2015 to November 9, 2015

Practice Excellence

Education. Patient Care. Leadership.

Target Audience

  • All practicing allergists/immunologists
  • Fellows in allergy/immunology training programs
  • Primary care physicians who care for allergy patients
  • Allied health professionals in the field of allergy and immunology 

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Identify major advances in key areas of cutting edge research in immunologic mechanisms and allergic responses, including anaphylaxis and pathophysiology of the upper airways, lungs, eyes, skin and gastrointestinal tract
  • Demonstrate knowledge of basic processes linking molecular and cellular biology and genetics with allergic pathophysiology and immunodeficiency
  • Translate emerging clinical science principles to clinical practice in patients with allergic and immunologic diseases
  • Evaluate and implement state-of-the-art diagnostic and therapeutic strategies for treating patients with allergic and immunologic diseases
  • Explain the impact of environmental exposures and external influences on patients with allergic disorders
  • Recognize emerging trends in the prevalence of allergic and immunologic disorders and discuss their impact on public health
  • Evaluate the impact of new diagnostic and therapeutic strategies on health care costs and outcomes
  • Discuss processes, tools and technologies for the efficient allergy and immunology practice
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

Cem Akin, MD, PhD
Consultant/Advisor: Blueprint Medicines, Novartis,
Patara Pharma; Supported/Contracted Research: Dyax
Thomas B. Casale, MD, FACAAI
Consultant/Advisor: AstraZeneca, Genentech, Novartis,
Sanofi, Teva
Craig A. Alter, MD
Consultant/Advisor: Pfizer
Bradley E. Chipps, MD, FACAAI
Consultant/Advisor: AstraZeneca, Boehringer
Ingelheim, Genentech, Merck, Novartis; Speaker:
AstraZeneca, Boehringer Ingelheim, Genentech,
Merck, Novartis; Supported/Contracted Research:
Stallergenes
Leonard B. Bacharier, MD, FACAAI
Consultant/Advisor: Boehringer Ingelheim, DBV
Technologies, GlaxoSmithKline, Meda,Teva; Speaker:
AstraZeneca, Novartis
Ray S. Davis, MD, FACAAI
Consultant/Advisor: Alcon, AstraZeneca, Baxter, Meda,
Merck, Teva
Mark M. Ballow, MD, FACAAI
Consultant/Advisor: CSL Behring, Kedrion; Supported/
Contracted Research: CSL Behring; Speaker: Baxter
§ Chitra Dinakar, MD, FACAAI
Consultant/Advisor: Aerocrine; Supported/Contracted
Research: GlaxoSmithKline, Merck, Teva
Gregory W. Bensch, MD, FACAAI
Consultant/Advisor: AstraZeneca, Teva; Supported/
Contracted Research: AstraZeneca, Boehringer
Ingelheim, Pearl, Teva
Mark S. Dykewicz, MD, FACAAI
Consultant/Advisor: Merck; Supported/Contracted
Research: Novartis
J. Andrew Bird, MD, FACAAI
Speaker: Nutrica; Supported/Contracted Research:
Aimmune Therapeutics, DBV Technologies
David B. Engler, MD, FACAAI
Stock: Regeneron
Mark Boguniewicz, MD, FACAAI
Consultant/Advisor: Celgene, Regeneron; Supported/
Contracted Research: Anacor
Elizabeth A. Erwin, MD
Stock: Pfizer
Larry Borish, MD, FACAAI
Consultant/Advisor: Allakos, Knopp, Novartis,
PluriStem
Stanley M. Fineman, MD, MBA, FACAAI
Speaker: AstraZeneca, Genentech, Meda, Merck,
Mylan; Supported/Contracted Research: Genentech,
Meda
John C. Browning, MD, MBA
Supported/Contracted Research: Anacor, MedImmune,
Regeneron
David M. Fleisher, MD
Consultant/Advisor: Food Allergy Research &
Education, LabCorp, National Peanut Board,
Receptors, Nestle Nutrition Institute; Supported/
Contracted Research: Monsanto Company, Nestle
Nutrition Institute
A. Wesley Burks, MD, FACAAI
Consultant/Advisor: Dynavax Technologies,
Genentech, GLG Research, Intrexon, Perrigo,
Perosphere, Regeneron, SRA International, Sanofi,
Valeant; Board Member (for profit organization)
Stallergenes
§ Luz S. Fonacier, MD, FACAAI
Speaker: Baxter; Supported/Contracted Research:
Baxter, Genentech, Merck
§ B. Gwen Carlton, DNP, APRN, FNP-BC
Speaker: Genentech
David M. Lang, MD, FACAAI
Consultant/Advisor: Genentech, GlaxoSmithKline,
Meda, Merck; Speaker: Genentech; Supported/
Contracted Research: Genentech, Merck
Lene Heise Garvey, MD, PhD
Consultant/Advisor: Merck; Speaker: Thermo Fisher
Scientific
Bob Lanier, MD, FACAAI
Supported/Contracted Research: Merck, Novartis,
Teva; Speaker: Genentech, Merck
Maureen George, PhD, RN, AE-C
Consultant/Advisor: Teva; Speaker: Teva
§ Phillip L. Lieberman, MD, FACAAI
Consultant/Advisor: Genentech, Mylan, Teva, Valeant;
Speaker: Meda
§ Richard G. Gower, MD, FACAAI
Consultant/Advisor: CSL Behring, Dyax, Mylan, Shire,
Teva; Medical Director: HollisterStier; Speaker: CSL
Behring, Mylan, Shire, Teva; Supported/Contracted
Research: Anacor, Biocryst, Circassia, CSL Behring,
Dyax, Genentech, GlaxoSmithKline, Kedrion, Mylan,
Optinose, Pearl, Regeneron, Shire, Teva; Stock: Merck
Peter A. Lio, MD
Consultant/Advisor: Anacor, Galderma, Johnson &
Johnson, Pierre Fabre, Valeant
David F. Graft, MD, FACAAI
Consultant/Advisor: Aerocrine; Speaker: Merck
William R. Lumry, MD, FACAAI
Consultant/Advisor: Biocryst, CSL Behring, Dyax, Shire;
Speaker: CSL Behring, Dyax, Shire, Teva; Supported/
Contracted Research: ADMA Biologics, Biocryst,
Circassia, CSL Behring, Dyax, Kedrion, Mylan, Novartis,
Roche, Shire, Teva
Mitchell H. Grayson, MD, FACAAI
Supported/Contracted Research: Polyphor
§ Todd A. Mahr, MD, FACAAI
Speaker: Aerocrine, Genentech, GlaxoSmithKline,
Meda, Merck, Mylan, Sanofi, Teva
§ Matthew Greenhawt, MD, MBA, MSc, FACAAI
Consultant/Advisor: National Peanut Board;
Supported/Contracted Research: National Center for
Translational Sciences
Michael E. Manning, MD, FACAAI
Consultant/Advisor: Dyax, Shire; Speaker: Baxter, CSL
Behring, Dyax, Genentech, Merck, Shire; Supported/
Contracted Research: Amgen, AstraZeneca, Biocryst,
Dyax, Genentech, Janssen, Johnson & Johnson,
Merck, Novartis, Sanofi, Shire, Teva
Gary N. Gross, MD, FACAAI
Supported/Contracted Amgen, Genentech, Janssen,
Mylan, Perrigo, Sanofi, Teva; Speaker: Merck, Teva
Kelly M. Maples, MD, FACAAI
Speaker: Teva
Ruchi Gupta, MD, MPH
Speaker: Mylan Specialty; Supported/Contracted
Research: Food Allergy Research & Education, Mylan
Gailen D. Marshall, MD, PhD, FACAAI
Supported/Contracted Research: Amgen, AstraZeneca,
National Institutes of Health (NIH)
Nicola A. Hanania, MD, MS
Consultant/Advisor: AstraZeneca, Meda, Novartis,
Pfizer, Roche, Sunovion; Speaker: Genentech;
Supported/Contracted Research: Boehringer
Ingelheim, Chiesi, Genentech, GlaxoSmithKline, Mylan,
Novartis, Pfizer, Roche, Sunovion
• § Kevin P. McGrath, MD FACAAI
Speaker: Teva
Mary Lou Hayden, MSN, FNP-BC, AE-C
Consultant/Advisor: Boehringer Ingelheim, Mylan, Teva
J. Allen Meadows, MD, FACAAI
Consultant/Advisor: Pfizer; Stocks: Johnson & Johnson
Erika Jensen-Jarolim, MD
Speaker: Allergy Therapeutics, Meda, Roxall, Thermo
Fisher Scientific; Stocks: Biomedical International R&D
Vienna, AllergyCare Vienna
Eli O. Meltzer, MD, FACAAI
Consultant/Advisor: AstraZeneca, Boehringer
Ingelheim, Circassia, GlaxoSmithKline, Greer, Johnson
& Johnson, McNeill, Meda, Merck, Regeneron, Sanofi,
Sunovion, Teva, Takeda, Valeant; Speaker: Alcon,
Greer, Meda, Mylan, Sunovion, Teva, Takeda
§ Rohit K. Katial, MD, FACAAI
Consultant/Advisor: AstraZeneca, GlaxoSmithKline,
Meda, Teva; Speaker: GlaxoSmithKline, Meda
Anthony Montanaro, MD, FACAAI
Supported/Contracted Reearch: Circassia, Genentech,
GlaxoSmithKline, Merck, Teva
§ David A. Khan, MD, FACAAI
Speaker: Baxter, Genentech
Harold S. Nelson, MD, FACAAI
Consultant/Advisor: AstraZeneca, Circassia, Merck,
Pearl Therapeutics; Supported/Contracted Research:
Circassia
Lisa K. Kobrynski, MD, MPH, FACAAI
Supported/Contracted Research: Baxter; Speaker:
Baxter, CSL Behring
William S. Silvers, MD, FACAAI
Speaker: Teva
Jerald W. Koepke, MD, FACAAI
Supported/Contracted Research: Sanofi
Roland Solensky, MD
Supported/Contracted Research: AstraZeneca, Merck
Anna H. Nowak-Wegrzyn, MD, FACAAI
Consultant/Advisor: Merck, Nestle; Speaker: Sanofi;
Supported/Contracted Research: DBV Technologies,
Food Allergy Research & Education, NIH/NIAID, ITN,
Nutricia
§ Brett Stanaland, MD, FACAAI
Speaker: Alcon, Meda, Merck, Teva
Talal M. Nsouli, MD, FACAAI
Consultant/Advisor: Teva; Speaker: Perrigo, Thermo
Fisher Scientific
§ James L. Sublett, MD, FACAAI
Consultant/Advisor: Boston Scientific, Greer;
Speaker: Genentech, GlaxoSmithKline, Meda, Merck,
Sunovion, Teva; Supported/Contracted Research:
Array BioPharma, AstraZeneca, Boehringer Ingelheim,
Forest, Mylan, Sanofi: Stock: AllergyZone
§ Maeve E. O’Connor, MD, FACAAI
Consultant/Advisor: Novartis; Speaker: Aerocrine,
Baxter, Dyax, Greer, Meda, Merck, Mylan, Teva,
Thermo Fisher Scientific
§ Stephen A. Tilles, MD, FACAAI
Supported/Contracted Research: Amgen, Astellas,
AstraZeneca, Biota, Circassia, DBV Technologies,
Genentech, Merck, Mylan, Novartis, Perrigo, Teva
§ John J. Oppenheimer, MD, FACAAI
Consultant/Advisor: GlaxoSmithKline, Meda, Mylan;
Supported/Contracted Research: AstraZeneca,
MedImmune, Novartis
James M. Tracy, DO, FACAAI
Consultant/Advisor: Johnson and Johnson, Pfizer;
Stock: Johnson & Johnson
Jordan S. Orange, MD, PhD, FACAAI
Consultant/Advisor: ADMA Biologics, ASD Healthcare,
Baxter, CSL Behring, Walgreens
Carina Venter, PhD, RD
Consultant/Advisor: Mead Johnson, Nestle; Speaker:
Nutricia; Supported/Contracted Research: Thermo
Fisher Scientific
Reynold A. Panettieri, Jr., MD
Consultant/Advisor: AstraZeneca, Johnson & Johnson;
Supported/Contracted Research: Gilead, Johnson &
Johnson, Merck, Roche, Sanofi
Christine W. Wagner, MSN, RN, CPNP, AE-C
Speaker: Teva
Anju T. Peters, MD, FACAAI
Consultant/Advisor: Baxter, Greer, Meda; Speaker:
Celgene
Julie Wang, MD, FACAAI
Consultant/Advisor: JDP Therapeutics, Merck
Stephen P. Peters, MD, PhD
Consultant/Advisor: AstraZeneca, Boehringer
Ingelheim, CSL Behring, Gilead, Merck, Novartis,
Pfizer, Teva, PPD Development, Quintiles, Theron
Richard L. Wasserman, MD, PhD, FACAAI
Consutlant/Advisor: ADMA Biologics, Baxter, Bio
Products Lab, CSL Behring, Grifols, Kedrion, ProMetic,
Therapure Biopharma; Speaker: Baxter, CSL Behring;
Supported/Contracted Research: ADMA Biologics,
Baxter, Bio Products Labs, CSL Behring, Kedrion,
Merck, Perrigo, Sanofi, Teva
§ Michael Pistiner, MD, MMSc, FACAAI
Stock: AllergyHome.org
Stephen I. Wasserman, MD, FACAAI
President: ABAI; consultant(sp): Pathway Genomics
Jay M. Portnoy, MD, FACAAI
Speaker: Mylan, Thermo Fisher Scientific
Richard W. Weber, MD, FACAAI
Consultant/Advisor: Genentech; Speaker: AstraZeneca,
Meda, Merck
Marc A. Riedl, MD, MS
Consultant/Advisor: Baxter, BioCryst, CSL Behring,
Dyax, Salix, Shire: Speaker: Baxter, CSL Behring, Dyax,
Salix, Shire: Supported/Contracted Research: Amgen,
Biocryst, CSL Behring, Dyax, Shire
Bruce L. Zuraw, MD, FACAAI
Consultant/Advisor: BioCryst, CSL Behring, Dyax,
Genentech, Isis, Novartis, Sanofi, Shire
§ Deidra H. Sanders, MSN, APRN, FNP-BC
Consultant/Advisor: Meda; Stock: AllergyZone
 
§ Charles J. Siegel, MD, FACAAI
Consultant/Advisor: Meda; Speaker: Meda, Teva
 
  
• = Planner §= Moderator 


The following have no financial relationships to disclose:

Juan Adams, MDNabeel Farooqui, MD
Karla Adams, MDTracy Fausnight, MD, FACAAI
David B. Allen, MDAlessandro Fiocchi, MD, FACAAI (SC)
§ Amal H. Assa’ad, MD, FACAAI§ Michael B. Foggs, MD, FACAAI
§ Sami L. Bahna, MD, DrPH, FACAAI§ Karen A. Freedle, MD, FACAAI
Aleena Banerji, MDTheodore M. Freeman, MD, FACAAI
Charles Barnes, PhDMarianne N. Frieri, MD, PhD, FACAAI
Rachel Bean, MDPinkus Goldberg, MD, FACAAI
Avraham Beigelman, MDPaul A. Greenberger, MD, FACAAI
Joseph A. Bellanti, MD, FACAAIMagdalena Grzyb, MD
• § Cheryl K. Bernstein, BSN, RN, CCRCMalike Gupta, MD
• § David I. Bernstein, MD, FACAAIDaniel L. Hamilos, MD, FACAAI
Leonard Bielory, MD, FACAAII. Celine Hanson, MD, FACAAI
§ Theresa A. Bingemann, MD, FACAAIJill Hanson, MD
Cheryl Blackwell, BSN, RN, AE-CCurtis Hedberg, MD, FACAAI
Hannelore A. Brucker, MD, FACAAI (SC)Alice Hoyt, MD
Paula Busse, MDFred H. Hsieh, MD, FACAAI
Ronna L. Campbell, MD, PhDKuan-Hsiang G. Huang, MD, PhD
Mariana C. Castells, MD, PhD, FACAAIYvonne Huang, MD
§ Helen Hei-ling Chan, MD, FACAAIElliot Israel, MD
Mirna Chehade, MD, MPH• Charlotte M. Jacobsen, MSN, RN
Meng Chen, MDJaison Jose, DO
Robert Chiffelle, MHSARobert J. Karman, MD
Seong H. Cho, MDMichael D. Keller, MD
Melanie Chong, MD• John M. Kelso, MD, FACAAI
Christina E. Ciaccio, MD, MSc, FACAAIRebecca Koransky, MD
• Kimberly G. Clay, MN, APRN, FNP-BC• Tao T. Le, MD, MHS, FACAAI
David E. Cohen, MD§ Gerald B. Lee, MD
Kevin Cook, MDRobert F. Lemanske, MD, FACAAI
• Mark L. Corbett, MD, FACAAI• § James T. Li, MD, PhD, FACAAI
• Peter S. Creticos, MDSamantha Lin, MD
Howard C. Crisp, MDBaojuan Liu
Mark A. Davis-Lorton, MD, FACAAI• § Bryan L. Martin, DO, FACAAI
Ves Dimov, MDFernando D. Martinez, MD
Nicholas DitzlerHannia Matt, MD
• § William K. Dolen, MD, FACAAIStephanie Mawhirt, DO
Steve Dorman, MDJacek Mazurek, MD
Dumitru Moldovan, MDPeter C. Schalock, MD
• Kevin R. Murphy, MD, FACAAI (SC)William T. Shearer, MD, PhD
Kari C. Nadeau, MD, PhDMichael Sherenian, MD
Naveen Nannapaneni, MD• § Jodi Shroba, MSN, APRN, CPNP
Maya Nanda, MD, MScMili Shum, MD
Elham A. Nekoo, MDWilliam S. Silvers, MD
Michael R. Nelson, MD, PhD, FACAAIDavid P. Skoner, MD, FACAAI
Victoria NelsonRaymond S. Slavin, MD, FACAAI
• § Andrew Nickels, MD• Sheldon L. Spector, MD, FACAAI
Noreen H. Nicol, PhD, RN, FNP, NEA-BCJonathan M. Spergel, MD, PhD, FACAAI
Irum Noor, DOSarah Spriet, DO
Lois M. Nora, MD, JD, MBAWhitney Stevens, MD, PhD
Safa Nsouli, MDPatricia H. Stewart, MD
Mark T. O’Hollaren, MD, FACAAIJames W. Sublett, MD, FACAAI
Grant C. Olson, MD, FACAAIMichael S. Tankersley, MD, FACAAI
Roy A. Orden, MDJames S. Taylor, MD
Thamiris Palacios, DOMary C. Tobin, MD, FACAAI
Dipika R. Patel, MDStephen K. Tsui, PhD
Neha N. Patel, MDJanna M. Tuck, MD, FACAAI
Priya Patel, MDJoseph C. Turbyville MD, FACAAI
Sheenal Patel, MD• Kay Tyler, BS, BA, MBA
David L. Patterson, MD, MBA, MS, FACAAIPeter Vadas, MD, PhD
Tammy Peng, MD• § Dana V. Wallace, MD, FACAAI
Maureen M. Petersen, MD, FACAAIKathryn R. Wessell, DO
Thomas A. Platts-Mills, MD, FACAAIC. Ross Westley, MD, FACAAI
Brooke I. Polk, MDMartha White, MD, FACAAI
Donald W. Pulver, MD, FACAAIP. Brock Williams, PhD, FACAAI (SC)
Vijay Ramakrishnan, MDAndrew Winslow, MD
Avner Reshef, MDPriscilla Wong, MD
Lanny J. Rosenwasser, MD, FACAAIShijun Xi, MD
• John M. Routes, MD, FACAAIKenneth Yeager, PhD
Tara V. Saco, MDCherie Y. Zachary, MD, FACAAI
Steve Shah, MDMyron Zitt, MD, FACAAI
  
• = Planner §= Moderator 

























• = Planner §= Moderator

Course summary
Available credit: 
  • 39.00 AMA PRA Category 1 Credit™
  • 39.00 Attendance
Course opens: 
11/05/2014
Course expires: 
11/10/2014
Event starts: 
11/05/2015 - 6:48am
Event ends: 
11/09/2015 - 4:49pm
Cost:
$0.00
Henry B. Gonzalez Convention Center
San Antonio, TX
United States

All identified conflicts of interest have been resolved.

 Grant Anhalt, PhD

Consultant/Advisory Board: GlaxoSmithKline

Noga Askenazi, MD FACAAI

Stock: Johnson and Johnson

Amal Assa'ad, MD, FACAAI

Consultant/Advisory Board: Mead Johnson; Research Grant: DBV Technologies, Genentech, GlaxoSmithKline, Teva

Leonard Bacharier, MD, FACAAI

Consultant/Advisory Board: DVB Technologies, Merck, Teva; Speaker: Aerocrine, GlaxoSmithKline, Merck

Sami L. Bahna, MD, DrPH, FACAAI

Consultant/Advisory Board: Abbott; Speaker: Abbott; Honorarium: Abbott

Gregory Bensch, MD, FACAAI

Consultant, Speaker: Teva; Speaker: AstraZeneca.

William E. Berger, MD, MBA, FACAAI

Consultant/Advisory Board: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Speaker: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Honorarium: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Research Grant: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva

Jonathan A. Bernstein, MD, FACAAI

Consultant/Advisory Board: CSL Behring, Dyax, Meda, Shire, ViroPharma; Speaker: CSL Behring, Dyax, Meda, Shire, Teva, ViroPharma; Honorarium: CSL Behring, Dyax, Meda, Shire, Teva, Viropharma; Research Grant: CSL Behring, Dyax, Novartis, Shire, ViroPharma

Leonard Bielory, MD, FACAAI

Consultant/Advisory Board: Allergan, Bausch & Lomb, Merck, Pharmacal, Sanofi-Chattem; Speaker: Allergan, Bausch & Lomb, Merck; Honorarium: Allergan, Bausch & Lomb, Merck; Research Grant: Allergan, EPA; Stock: STARxTech

Clifton O. Bingham, III, MD

Consultant/Advisory Board: Abbvie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Roche, Janssen, Novartis, Novo Nordisk, Pfizer, UCB; Research Grant: Bristol-Myers Squibb, Janssen, UCB

Michael S. Blaiss, MD, FACAAI

Consultant/Advisory Board: Alcon, Allergan, Bausch & Lomb, Genentech, GlaxoSmithKline, JDP Therapeutics, Merck, Mylan, Pfizer, PMD Healthcare, Proctor & Gamble, Sanofi, Sunovion, Takeda, Teva; Speaker: Alcon, Allergan, AstraZeneca, Bausch & Lomb, Genentech, GlaxoSmithKline, Merck, Sunovion, Takeda

Don A. Bukstein, MD, FACAAI

Speaker: Aerocrine, AstraZeneca, Genentech, Merck, Novartis, Sunovion, Teva

A. Wesley Burks, MD, FACAAI

Consultant/Advisory Board: Dow AgroSciences, ExploraMed Development, Genalyte, Hycor, Mastcell Pharma, Merck, Nordic Biotech, Novartis, Perrigo Company, Regeneron, Unilever; Speaker: Mylan Specialty; Research Grant: Hycor; Stock: Allertein, Mylan Specialty

Peter A. Calabresi, MD

Consultant/Advisory Board:  Abbott, Vertex; Honorarium: Abbott, Vertex; Research Grant: Abbott, Bayer, Biogen Idec, Novartis, Vertex

Warner W. Carr, MD, FACAAI

Consultant/Advisory Board: Alcon, Allergan, Indegene, Meda; Speaker: Alcon, AstraZeneca, Meda, Teva; Honorarium: Alcon, Allergan, AstraZeneca, Indegene, Meda, Teva; Research Grant: Adrea, Forest, Sunovion

Thomas B. Casale, MD, FACAAI

Consultant/Advisory Board: Genentech, Novartis

Adrian M. Casillas, MD, FACAAI

Research Grant: CSL Behring

Bradley E. Chipps, MD, FACAAI

Consultant/Advisory Board: AstraZeneca, Mylan Specialty, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion; Speaker: AstraZeneca, Bausch & Lomb, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion; Honorarium: AstraZeneca, Bausch & Lomb, Mylan Specialty, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion

Mark L. Corbett, MD, FACAAI

Speaker: AstraZeneca, Merck, Sunovion, Teva

Linda Cox, MD, FACAAI

Consultant/Advisory Board: Genentech, Stallergenes; Speaker: Stallergenes

Timothy M Craig, DO, FACAAI

Consultant/Advisory Board: CSL Behring, Dyax. Merck; Speaker: CSL Behring, Dyax, Genentech/Novartis, Merck, Shire, ViroPharma; Honorarium: CSL Behring, Dyax, Genentech/Novartis, Merck, Shire, ViroPharma; Research Grant: CSL Behring, Dyax, Genentech/Novartis, GlaxoSmithKline, Merck, Pharming, Shire, ViroPharma

Peter S. Creticos, MD

Consultant/Advisory Board: Circassia, Greer, Merck; Research Grant: Circassia, Greer, Merck

Chitra Dinakar, MD, FACCAI

Speaker: Aerocrine, Teva; Honorarium: Aerocrine, Teva

Paul Dowling, MD, FACAAI

Speaker: Research Grant: GlaxoSmithKline, Merck

Mark S. Dykewicz, MD, FACAAI

Consultant/Advisory Board: Merck; Honorarium: Merck

Daniel Ein, MD, FACAAI

Consultant/Advisory Board: Allergan

Renata Engler, MD, FACAAI

Research Grant: National Institutes of Health, Stock: Stellar Biotech

Stanley M. Fineman, MD, MBA, FACAAI

Speaker: AstraZeneca, Genentech/Novartis, Sunovion; Research Grant: Genentech/Novartis, Shionogi, Sunovion

Michael B. Foggs, MD, FACAAI

Consultant/Advisory Board: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hycor, Merck; Speaker: AstraZeneca, GlaxoSmithKline, Merck; Honorarium: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hycor, Merck

Luz S. Fonacier, MD, FACAAI

Speaker: Baxter; Honorarium: Genentech; Research Grant: Baxter, Dyax, Genentech, Merck

Pinkus Goldberg, FACAAI

Consultant/Advisory Board: Allergan; Speaker: Genentech, Meda, Merck, Mylan, Novartis; Research Grant: Circassia, Genentech, GlaxoSmithKline, Meda, Merck, Novartis, Teva 

Richard G. Gower, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, CSL Behring, Mylan Specialty, Dyax, Genentech, HollisterStier, Mylan, Novartis, Roche, Sanofi, Shire, Teva, ViroPharma; Speaker: Bausch & Lomb, CSL Behring, Mylan, Genentech, Novartis, Roche, Shire, Teva, ViroPharma; Honorarium: Bausch & Lomb, CSL Behring, Genentech, Mylan, Novartis, Roche, Shire, Teva, ViroPharma; Research Grant: Bausch & Lomb, Boehringer Ingelheim, Circassia,  CSL Behring, Eli Lilly, Genentech, GlaxoSmithKline, Green Cross, Kedrion, Mylan, Novartis, Pharming, Roche, Shire, Teva, ViroPharma; Stock: Merck

Matthew Greenhawt, MD, MBA, MSc

Consultant/Advisory Board: Nutricia; Research Grant: National Institutes of Health; Speaker: Nutricia; Honorarium: Nutricia

Vivian Hernandez-Trujillo, MD, FACAAI

Consultant/Advisory Board: Baxter, Merck, Sanofi; Speaker: Baxter, CSL Behring, Merck, Sanofi

Lewis Kanter, MD, FACAAI

Speaker: Alcon, Meda, Sunovion, Teva

Rohit K. Katial, MD, FACAAI

Consultant/Advisory Board: Teva; Honorarium: Teva

David A. Khan, MD, FACAAI

Speaker: Baxter, Genentech, Merck, ViroPharma; Honorarium: Baxter, Genentech, Merck, ViroPharma

Monica Kraft, MD

Research Grant: Boston Scientific, Eumedics, Genentech, GlaxoSmithKline, Merck, National Institutes of Health, Novartis

Charles J. Lane, MD

Speaker: GlaxoSmithKline; Honorarium: Mylan Specialty

Bobby Q. Lanier, MD, FACAAI

Consultant/Advisory Board: Merck, Novartis; Speaker: Merck, Novartis; Research Grant: Teva

James T. Li, MD, PhD, FACAAI

Stocks: Abbott, Johnson & Johnson, Novartis

Phillip L. Lieberman, MD, FACAAI

Consultant/Advisory Board: Meda, Mylan, Sanofi; Speaker: Meda, Mylan; Honorarium: Meda, Mylan

Todd A. Mahr, MD, FACAAI

Consultant/Advisory Board: Mylan, Sanofi; Speaker: Aerocrine, Genentech, GlaxoSmithKline, Mylan, Sanofi; Honorarium: Aerocrine, Genentech, GlaxoSmithKline, Mylan, Sanofi

Lyndon Mansfield, MD, FACAAI

Consultant/Advisory Board: Genentech; Speaker: Sunovion, Teva

Gailen D. Marshall, Jr., MD, PhD, FACP, FACAAI

Research Grant: Teva, National Institutes of Health, Health Resources and Services Administration

Kevin P. McGrath, MD, FACAAI

Speaker: Sunovion

Travis A. Miller, MD, FACAAI

Consultant/Advisory Board: Meda, Sunovion; Speaker: Alcon, AstraZeneca, Bausch & Lomb, GlaxoSmithKline, Meda, Merck, Mylan, Novartis, Sunovion, Teva; Honorarium: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Merck, Mylan, Novartis, Sunovion; Teva

Anthony Montanaro, MD, FACAAI

Research Grant: Boehringer Ingelheim, Genentech, GlaxoSmithKline, Merck, Novartis, Teva

Harold S. Nelson, MD, FACAAI

Consultant/Advisory Board: Merck, Shionogi: Honorarium: Merck, Pearl, Shionogi; Research Grant: Circassia, Lincoln Diagnostics, Rigel

Talal M. Nsouli, MD, FACAAI

Consultant/Advisory Board: Thermo Fisher Scientific, Sunovion, Teva; Speaker: Thermo Fisher Scientific, Sunovion, Teva

John J. Oppenheimer, MD, FACAAI

Consultant/Advisory Board: AstraZeneca, GlaxoSmithKline, Mylan, Sunovion; Research Grant: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline

Nancy K. Ostrom, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, Meda, Merck, Teva; Speaker: AstraZeneca, GlaxoSmithKline, Meda, Merck, Novartis, Sunovion, Teva; Research Grant: Apotex, AstraZeneca, Boehringer Ingelheim, ElectroCore, GlaxoSmithKline, MedImmune, Merck, Nestle, Novartis, Rigel, Sunovion, Teva, Actavis

Thomas A.E. Platts-Mills, MD, PhD, FACAAI

Consultant/Advisory Board: ViraCor-IBT, Speaker: ALK-Abello; Honorarium: ALK-Abello, Thermo Fisher Scientific; Research Grant: Thermo Fisher Scientific

Jay M. Portnoy, MD, FACAAI

Consultant/Advisory Board: Sanofi, Thermo Fisher Scientific; Speaker: Mylan, Thermo Fisher Scientific; Honorarium: Mylan, Sanofi, Thermo Fisher Scientific

Marc A. Riedl, MD, MS

Consultant/Advisory Board: BioCryst, CSL Behring, Dyax, Shire, ViroPharma; Speaker: CSL Behring, Dyax, Shire, ViroPharma; Research Grant: CSL Behring, Dyax, Shire, ViroPharma

Ketan Sheth, MD, MBA, FACAAI

Consultant/Advisory Board: Teva; Speaker: GlaxoSmithKline, Teva; Honorarium: GlaxoSmithKline, Teva; Stocks: Merck

Charles J. Siegel, MD, FACAAI

Consultant/Advisory Board: Meda, Teva; Speaker: Meda, Teva; Honorarium: Meda, Mylan, Teva

David P. Skoner, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, Merck, Sunovion; Speaker: GlaxoSmithKline, Merck, Novartis, Sunovion, Teva; Research Grant: GlaxoSmithKline, Greer, Merck, Novartis, Teva

Brett E. Stanaland, MD, MS, FACAAI

Consultant/Advisory Board: Sunovion, Teva; Speaker: Meda, Merck, Sunovion, Teva

Gary C. Steven, MD, PhD, FACAAI

Speaker: Merck, Novartis, Teva; Research Grant: Merck, AstraZeneca, Circassia, Genentech, Mylan, Novartis, Novum, Optinose, Concentric, Pulmagen, GlaxoSmithKline, Teva

James L. Sublett, MD, FACAAI

Consultant/Advisory Board: Aerocrine, GlaxoSmithKline, Meda, Merck, Sunovion, Teva; Speaker: GlaxoSmithKline, Merck, Sunovion, Teva; Honorarium: GlaxoSmithKline, Merck, Sunovion, Teva; Research Grant: GlaxoSmithKline, Merck, Novartis, Sunovion, Teva, 

Stanley J. Szefler, MD, FACAAI

Consultant/Advisory Board: Boehringer Ingelheim, GlaxoSmithKline, Merck, Roche; Speaker: Merck; Honorarium: Genentech; Research Grant: Boehringer Ingelheim, GlaxoSmithKline

Stephen A. Tilles, MD FACAAI

Consultant/Advisory Board: Bausch & Lomb, Hycor, Merck, Mylan, Sunovion

Janna M. Tuck, MD, FACAAI

Stocks: Advanced Cell Technology, Cel-Sci, Synergy

Dana V. Wallace, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, Mylan, Sanofi, Sunovion, Teva

Richard W. Weber, MD, FACAAI

Consultant/Advisory Board: Genentech; Speaker: Merck; Research Grant: Novartis

 

The following have no relevant financial relationships to disclose:

Joseph A. Bellanti, MD, FACAAI

Monica Bhagat, MD

Christina Ciaccio, MD, FACAAI

John O. Clarke, MD

Vesselin Dimov, MD

Nemr S. Eid, MD

Shari M. Erickson, MPH

Alessandro Fiocchi, MD, FACAAI (SC)

Karen A. Freedle, MD, FACAAI

Curtis L. Hedberg, MD, FACAAI

Kirsi Jarvinen-Seppo, MD, PhD

John M. Kelso, MD, FACAAI

Tao T. Le, MD, MHS, FACAAI

Alnoor A. Malick, MD, FACAAI

Jennifer Mammen, MD

Bryan L. Martin, DO, FACAAI

Kathleen May, MD, FACAAI

Michael Nelson, MD, PhD, FACAAI

Myngoc T. Nguyen, MD, FACAAI

Richard A. Nicklas, MD, FACAAI

Maeve O'Connor, MD, FACAAI

Mark T. O'Hollaren, MD, FACAAI

Gurusher Panjrath, MD

Kavita Patel, MD

Joram S. Seggev, MD, FACAAI

Meagan Shepherd, MD

David R. Weldon, MD, FACAAI

Education Staff/Committee/Reviewers have no relevant financial relationships to disclose, except as may be listed above.

Available Credit

  • 39.00 AMA PRA Category 1 Credit™
  • 39.00 Attendance

Accreditation Period

Course opens: 
11/05/2014
Course expires: 
11/10/2014

Price

Cost:
$0.00
Please login or create an account to take this course.